FUJIFILM Biosciences and NextCell launch new commercial platform comprised of RUO stromal cells and cell culture media

FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company specializing in cell therapy using umbilical cord mesenchymal stromal cells (MSC), today announced a global commercial launch resulting from their strategic collaboration.

Leave a Reply